Michael J. Sofia
CIK 1635324 · View on SEC EDGAR ↗
First SEC filing: March 16, 2015 · Latest: March 16, 2015
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 11, 2018 | ABUS | S 10b5-1 | 10,000 | $10.00 | $100,000 | 1,503,403 Direct | -0.66% | Disposed | -49.9% (price as of 2026-08-19) |
| July 9, 2018 | ABUS | S 10b5-1 | 10,000 | $8.91 | $89,100 | 1,513,403 Direct | -0.66% | Disposed | -43.8% (price as of 2026-08-19) |
| July 6, 2018 | ABUS | S 10b5-1 | 10,000 | $8.45 | $84,500 | 1,523,403 Direct | -0.65% | Disposed | -40.7% (price as of 2026-08-19) |
| July 5, 2018 | ABUS | S 10b5-1 | 10,000 | $8.40 | $84,000 | 1,533,403 Direct | -0.65% | Disposed | -40.4% (price as of 2026-08-19) |
| July 3, 2018 | ABUS | S 10b5-1 | 10,000 | $8.00 | $80,000 | 1,543,403 Direct | -0.64% | Disposed | -37.4% (price as of 2026-08-19) |
| Oct. 3, 2017 | ABUS | S 10b5-1 | 10,000 | $8.00 | $80,000 | 1,553,403 Direct | -0.64% | Disposed | -37.4% (price as of 2026-08-19) |
| Aug. 15, 2017 | ABUS | S | 20,000 | $3.68 | $73,600 | 171,412 Indirect | -10.45% | Disposed | 36.1% (price as of 2026-08-19) |
| Aug. 15, 2017 | ABUS | S | 10,000 | $3.75 | $37,500 | 191,412 Indirect | -4.96% | Disposed | 33.6% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 1, 2019 | ABUS | Employee Stock Option (Right to Buy) | Common Shares (145,000) | $4.57 | March 1, 2029 | 145,000 | Acquired |
| April 16, 2018 | ABUS | Employee Stock Option (Right to Buy) | Common Stock (160,000) | $5.20 | April 16, 2028 | 160,000 | Acquired |
| March 24, 2017 | ABUS | Employee Stock Option (Right to Buy) | Common Stock (150,000) | $3.15 | March 24, 2027 | 150,000 | Acquired |
| March 15, 2016 | ABUS | Employee Stock Option (Right to Buy) | Common Shares (100,000) | $3.94 | March 15, 2026 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ABUS
Ph.D. Chief Scientific Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $492,000 | — | $238,380 | $720,208 | $147,600 | — | $16,500 | $1,614,688 |
| 2022 | $468,000 | — | — | $619,775 | $149,760 | — | $10,675 | $1,248,210 |
| 2021 | $452,100 | — | — | $938,944 | $207,966 | — | $10,150 | $1,609,160 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.